Advertisement
Bavarian Nordic A/S

Bavarian Nordic A/S (BVNRY) Stock Overview

Explore Bavarian Nordic A/S’s financial performance, market position, analyst ratings, and future outlook.

BVNRYā—PNK
HealthcareBiotechnology
$9.45
$0.10(1.07%)
U.S. Market opens in NaNh NaNm
Advertisement

Bavarian Nordic A/S (BVNRY)

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio12.00
EPS (TTM)$0.78
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$9.73
3 Months$10.69
1 Year Target$11.16

BVNRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bavarian Nordic A/S (BVNRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.00 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.02%
5-Day Change
-1.72%
1-Month Change
-8.30%
3-Month Change
3.68%
6-Month Change
-3.62%
Year-to-Date (YTD) Change
-4.88%
1-Year Change
-0.47%
3-Year Change
-9.18%
5-Year Change
-35.84%
All-Time (Max) Change
59.81%

Contact Information

45 33 26 83 83
Philip Heymans Alle 3, Hellerup, NaN, 2900

Company Facts

1,645 Employees
IPO DateApr 3, 2013
CountryDK
Actively Trading

Frequently Asked Questions